Skip to main content

Influenza virus vaccine, h5n1 Disease Interactions

There are 4 disease interactions with influenza virus vaccine, h5n1.

Major

Influenza vaccine (applies to influenza virus vaccine, h5n1) neurologic disorders

Major Potential Hazard, Moderate plausibility.

Influenza vaccine should be withheld, pending stabilization, in patients with active neurologic disorders associated with changing neurological status. Neurologic signs or symptoms following administration of an influenza vaccine is a contraindication to future use.

References

  1. "Product Information. Fluzone (influenza virus vaccine, inactivated)." Connaught Laboratories Inc
Major

Influenza virus vaccine H5N1 (applies to influenza virus vaccine, h5n1) Guillain-Barre Syndrome (GBS)

Major Potential Hazard, Moderate plausibility.

Careful consideration of the potential risks and benefits should be given before deciding to give the influenza virus vaccine H5N1 to any patient who developed GBS within 6 weeks of receipt of a prior influenza vaccine.

References

  1. (2022) "Product Information. Influenza Virus Vaccine, H5N1, Inactivated (influenza virus vaccine, H5N1, inactivated)." GlaxoSmithKline
Moderate

Influenza virus vaccine H5N1 (applies to influenza virus vaccine, h5n1) hemophilia

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Bleeding Associated with Coagulation Defect

As with other intramuscular injections, this vaccine should be given with caution in individuals with bleeding disorders, such as hemophilia or on anticoagulation therapy, to avoid the risk of hematoma following the injection.

References

  1. (2022) "Product Information. Influenza Virus Vaccine, H5N1, Inactivated (influenza virus vaccine, H5N1, inactivated)." GlaxoSmithKline
Moderate

Influenza virus vaccine H5N1 (applies to influenza virus vaccine, h5n1) immunodeficiency

Moderate Potential Hazard, Moderate plausibility.

If Influenza Virus Vaccine, H5N1, is administered to immunocompromised patients, including individuals receiving immunosuppressive therapy, the expected immune response may not be obtained.

References

  1. (2022) "Product Information. Influenza Virus Vaccine, H5N1, Inactivated (influenza virus vaccine, H5N1, inactivated)." GlaxoSmithKline

Influenza virus vaccine, h5n1 drug interactions

There are 288 drug interactions with influenza virus vaccine, h5n1.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer